ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 63 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,400,289 | $19,889,000 | 2.53% |
| ADAMS STREET PARTNERS LLC | 1,473,061 | $6,658,000 | 1.70% |
| Iguana Healthcare Management, LLC | 700,000 | $3,164,000 | 0.87% |
| Perceptive Advisors | 2,076,578 | $9,386,000 | 0.18% |
| Birchview Capital, LP | 28,689 | $130,000 | 0.07% |
| Cannell & Co. | 303,971 | $1,374,000 | 0.05% |
| ELEMENT CAPITAL MANAGEMENT LLC | 25,249 | $114,000 | 0.05% |
| NJ State Employees Deferred Compensation Plan | 38,000 | $172,000 | 0.03% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 313,775 | $1,418,000 | 0.03% |
| Candriam S.C.A. | 370,000 | $1,672,000 | 0.03% |